Costs of no testing, testing using BHIVA, testing using NICE strategies and testing all clinic attendees
| No testing | BHIVA testing | NICE testing | Testing all | |||||
| 2000–2005 | 2005–2010 | 2000–2005 | 2005–2010 | 2000–2005 | 2005–2010 | 2000–2005 | 2005–2010 | |
| Total cases of active TB under testing strategy n | 37 | 35 | 26 | 24 | 23 | 21 | 21 | 20 |
| Total cost of testing for LTBI | €0 | €0 | €74 006 | €80 007 | €121 234 | €149 328 | €142 528 | €187 242 |
| Average cost per patient of testing for LTBI | €0 | €0 | €34 | €28 | €55 | €51 | €65 | €65 |
| Total cost of preventive treatment | €0 | €0 | €63 482 | €76 471 | €68 317 | €92 899 | €82 778 | €115 631 |
| Average cost per patient of preventive treatment | €0 | €0 | €29 | €26 | €31 | €32 | €37 | €40 |
| Total cost of remaining active cases | €338 313 | €320 026 | €241 225 | €222 938 | €206 273 | €195 753 | €194 622 | €184 102 |
| Average cost per patient of remaining active cases | €153 | €110 | €109 | €77 | €93 | €67 | €88 | €63 |
| Total cost | €338 313 | €320 026 | €378 713 | €379 416 | €395 825 | €437 979 | €419 928 | €486 975 |
| Average cost per patient of entire strategy | €153 | €110 | €171 | €131 | €179 | €151 | €190 | €168 |
Data from 2000–2005 (n=2209) and 2005–2010 (n=2902). BHIVA: British HIV Association; NICE: National Institute for Health and Care Excellence; LTBI: latent tuberculosis infection.